Skip to main content
Premium Trial:

Request an Annual Quote

Made Up a Few Gene Sequences

A research technician at Washington State University was caught fabricating gene sequencing data and resigned, Retraction Watch reports.

It adds that the fabrication came to light when the technician, Ryan Evanoff, produced sequencing results that were completely different from what an outside lab had reported on the same samples. Robert Mealey, the chair of the department of veterinary clinical sciences department at WSU, tells RW that the school conducted a full investigation and that Evanoff left WSU before he could be fired.

RW notes that the fabrication affects at least two papers and that one, appearing in the Journal of Virology, has been retracted. That paper purported to examine intrahost evolution of hepacivirus A envelope variants, but, as the retraction notice says, the Pacific Biosciences sequencing data it relied on was fabricated. The other affected paper in the Equine Veterinary Journal is in the process of being retracted, according to RW.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.